Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study

Kenji Ishikura(Kitasato University), Masataka Honda(Rikkyo University), Koichi Nakanishi(University of the Ryukyus), Motoshi Hattori(Japanese Society for Dialysis Therapy), Tetsuji Kaneko(Teikyo University of Science), Shuichi Ito(Yokohama City University), Yasuo Ohashi(Chuo University), Osamu Uemura(Aichi Medical University), Ryojiro Tanaka(Kobe Children's Hospital), Naohiro Wada(Shizuoka Children's Hospital), Yuko Hamasaki(Toho University)
Nephrology Dialysis Transplantation
February 9, 2014
10.1093/ndt/gfu012
Cited by 38

Related Papers

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|242